Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.
2.

Outcome of positive antinuclear antibodies in individuals without connective tissue disease.

Myckatyn SO, Russell AS.

J Rheumatol. 2003 Apr;30(4):736-9.

PMID:
12672192
3.

Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.

Tzaneva S, Volc-Platzer B, Kittler H, Hönigsmann H, Tanew A.

Br J Dermatol. 2008 May;158(5):1050-4. doi: 10.1111/j.1365-2133.2008.08500.x. Epub 2008 Mar 13.

PMID:
18341657
4.

Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results.

Caramaschi P, Ruzzenente O, Pieropan S, Volpe A, Carletto A, Bambara LM, Biasi D.

Rheumatol Int. 2007 May;27(7):649-54. Epub 2006 Nov 29.

PMID:
17136355
5.

Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.

Vos PA, Bast EJ, Derksen RH.

Rheumatology (Oxford). 2006 May;45(5):629-35. Epub 2005 Dec 20.

PMID:
16368728
6.

The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up.

Wang KY, Yang YH, Chuang YH, Chan PJ, Yu HH, Lee JH, Wang LC, Chiang BL.

J Microbiol Immunol Infect. 2011 Jun;44(3):222-8. doi: 10.1016/j.jmii.2011.01.019. Epub 2011 Jan 19.

7.

Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria.

Shin JI, Kim KH, Chun JK, Lee TJ, Kim KJ, Kim HS, Kim DS.

Scand J Rheumatol. 2008 Sep-Oct;37(5):348-51. doi: 10.1080/03009740801998762.

PMID:
18666025
9.

Is there a predisposition for the development of autoimmune diseases in patients with fibromyalgia? Retrospective analysis with long term follow-up.

Kötter I, Neuscheler D, Günaydin I, Wernet D, Klein R.

Rheumatol Int. 2007 Sep;27(11):1031-9. Epub 2007 Jul 20.

PMID:
17634900
10.

Clinical associations of anti-lamin autoantibodies.

Hill C, Roberts-Thomson P, Pollard A, Gillis D, Kirkham B.

Aust N Z J Med. 1996 Apr;26(2):162-6.

PMID:
8744613
11.

From ANA to ENA: how to proceed?

Damoiseaux JG, Tervaert JW.

Autoimmun Rev. 2006 Jan;5(1):10-7. Epub 2005 Jun 13. Review.

PMID:
16338206
12.

Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.

Gulez N, Karaca NE, Aksu G, Kutukculer N.

Autoimmunity. 2009 Jan;42(1):74-9. doi: 10.1080/08916930802375711.

PMID:
19127458
13.

Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.

Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.

Joint Bone Spine. 2009 May;76(3):248-53. doi: 10.1016/j.jbspin.2008.09.010. Epub 2009 Feb 8.

PMID:
19208451
14.

Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.

Sousa JX Jr, Miyamoto D, Zimbres JM, Costa DV, Aoki V.

Clin Exp Dermatol. 2009 Apr;34(3):314-8. doi: 10.1111/j.1365-2230.2008.02947.x. Epub 2008 Nov 24.

PMID:
19040522
15.

Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.

Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Ferri S, Quarneti C, Cipriano V, de Molo C, Lenzi M, Chapman RW, Bianchi FB.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):831-8.

16.
17.

Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.

Agarwal S, Harper J, Kiely PD.

Lupus. 2009 Apr;18(5):407-12. doi: 10.1177/0961203308097784.

PMID:
19318392
18.

Outcome of high titer antinuclear antibody positivity in individuals without connective tissue disease: a 10-year follow-up.

Wijeyesinghe U, Russell AS.

Clin Rheumatol. 2008 Nov;27(11):1399-402. doi: 10.1007/s10067-008-0932-y. Epub 2008 May 24.

PMID:
18500432
19.

Favorable outcomes of autoimmune hepatitis in a community clinic setting.

Seo S, Toutounjian R, Conrad A, Blatt L, Tong MJ.

J Gastroenterol Hepatol. 2008 Sep;23(9):1410-4. doi: 10.1111/j.1440-1746.2008.05365.x. Epub 2008 Mar 27.

PMID:
18373564
20.

Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.

Chloraki-Bobota A, Megalakaki C, Repousis P, Chalkiopoulou I, Lalaki I, Trafalis DT, Athanassiou AE, Mitsouli-Mentzikof C.

J BUON. 2006 Oct-Dec;11(4):485-9.

PMID:
17309182

Supplemental Content

Support Center